Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

tumor microenvironment

  • You have access
    Determination of Cuproptosis-related Subtypes, Development of a Prognostic Model, and Characterization of Tumor Microenvironment Infiltration in Acute Myeloid Leukemia
    YUCHEN TAO, JIANYE REN, TINGTING XUE, YANLU WANG, HAO XU, HONGYU ZHANG and JIAHUI LU
    Anticancer Research September 2023, 43 (9) 3943-3960; DOI: https://doi.org/10.21873/anticanres.16582
  • You have access
    ATG9B Is a Poor Prognostic Marker Associated With Immune Evasion in Colon Adenocarcinoma
    IN SOO KIM, SANG YEON CHO, MISO YANG, SONGYEON HAN, KYUNG-HA LEE, JI YEON KIM, JIN MAN KIM, SORA KANG, EUN-KYEONG JO and HYEWON RYU
    Anticancer Research May 2023, 43 (5) 1943-1957; DOI: https://doi.org/10.21873/anticanres.16354
  • You have access
    TU-100 Antagonizes the M2 Polarization Phenotype of Macrophages in the Tumor Microenvironment by Suppressing the TLR4/NF-GraphicB/STAT3 Axis
    SHUHAI CHEN, YUJI MORINE, YU SAITO, SHINICHIRO YAMADA, HIROKI TERAOKU, TETSUYA IKEMOTO and MITSUO SHIMADA
    Anticancer Research May 2023, 43 (5) 1985-1992; DOI: https://doi.org/10.21873/anticanres.16359
  • You have access
    Epithelial–Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer
    CHUNG RYUL OH, HYUNG-DON KIM, YEON-MI RYU, SEONMIN LEE, DANBEE KIM, DA SOL LEE, JAE HO JEONG, HEUNG-MOON CHANG, BAEK-YEOL RYOO, KYU-PYO KIM, MIYEON KIM, SANG-YEOB KIM and CHANGHOON YOO
    Anticancer Research February 2023, 43 (2) 645-652; DOI: https://doi.org/10.21873/anticanres.16201
  • Open Access
    Inhibition of STAT3 Promotes Effector T Cell Infiltration But also Immunosuppression in the HCC Tumor Microenvironment
    TAKETO SASAKI, KOHEI SHIGETA, SHUJI KITAHARA, YASUHIRO SUZUKI, SHIMPEI MATSUI, RYO SEISHIMA, KOJI OKABAYASHI, DAN G. DUDA and YUKO KITAGAWA
    Anticancer Research November 2022, 42 (11) 5205-5215; DOI: https://doi.org/10.21873/anticanres.16027
  • You have access
    Effects of Cyclooxygenase-2 in Canine Melanoma-derived Extracellular Vesicles on Tumor Microenvironment In Vitro
    NA-HYEONG KIM, JU-HYUN AN, JEONG-HWA LEE, SU-MIN PARK, KYEONG-BO KIM, TAE-HYUN KIM, YE-IN OH, KYEONG-WON SEO and HWA-YOUNG YOUN
    Anticancer Research November 2022, 42 (11) 5397-5405; DOI: https://doi.org/10.21873/anticanres.16044
  • You have access
    Preparation of Micelles Encapsulating Doxorubicin and Their Anticancer Effect in Combination With Tranilast in 3D Spheroids and In Vivo
    TERUKI NII, KANJI YOSHIKAWA, ISSEI TAKEUCHI and KIMIKO MAKINO
    Anticancer Research June 2022, 42 (6) 2847-2857; DOI: https://doi.org/10.21873/anticanres.15766
  • You have access
    Epstein-Barr Virus-induced Gene 3 as a Novel Biomarker in Metastatic Melanoma With Infiltrating CD8+ T Cells: A Study Based on The Cancer Genome Atlas (TCGA)
    SATORU YONEKURA
    Anticancer Research January 2022, 42 (1) 511-517; DOI: https://doi.org/10.21873/anticanres.15509
  • You have access
    New Insights as to Why Progesterone Receptor Modulators, such as Mifepristone, Seem to Be More Effective in Treating Cancers that Are Devoid of the Classical Nuclear Progesterone Receptor
    JEROME H. CHECK and DIANE CHECK
    Anticancer Research December 2021, 41 (12) 5873-5880; DOI: https://doi.org/10.21873/anticanres.15407
  • You have access
    Involvement of Galectin-1 Tumor Microenvironment in Radiosensitivity
    YI-FAN CHEN, CHUNG-CHI WANG, CHIEH-YING HSU and ENG-YEN HUANG
    Anticancer Research May 2021, 41 (5) 2321-2331; DOI: https://doi.org/10.21873/anticanres.15007

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire